Recent research by Tao et al. demonstrated that the enhanced expression of CD36 could expedite the advancement of HCC by boosting the levels of aldo-keto reductases family 1 member C2 (AKR1C2) and enhancing the uptake of FAs [17]. Here, AKR1C2 is linked to hepatocellular carcinoma.